Bioequivalence and Pharmacokinetic Evaluation of 2 Pyrazinamide Formulations in Healthy Chinese Adults: A Single‐Dose, Open‐Label, Randomized‐Sequence, 2×2 Crossover Study
Author:
Affiliation:
1. Department of Pharmacy Second Hospital of Shanxi Medical University Taiyuan China
2. School of Pharmacy Shanxi Medical University Taiyuan China
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.1035
Reference10 articles.
1. Simultaneous determination of pyrazinamide, rifampicin, ethambutol, isoniazid and acetyl isoniazid in human plasma by LC‐MS/MS method;Luyen LT;J App Pharm Sci,2018
2. Evaluation of bioequivalence of isoniazid and pyrazinamide in three and four drugs fixed dose combinations using WHO simplified protocol;Panchagnula R;Pharmacol Res,2003
3. An improved LC‐MS/MS method for the simultaneous determination of pyrazinamide, pyrazinoic acid and 5‐hydroxy pyrazinoic acid in human plasma for a pharmacokinetic study;Shah PA;J Chromatogr B Analyt Technol Biomed Life Sci,2016
4. Protein binding of first‐line antituberculosis drugs;Alghamdi WA;Antimicrob Agents Chemother,2018
5. Pyrazinamide pharmacokinetics and efficacy in adults and children;Donald PR;Tuberculosis (Edinb),2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3